(CRSP) Crispr Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Crispr Therapeutics | (CRSP) share price targets
Complete technical analysis of Crispr Therapeutics (CRSP) by charts plus indicators, forecast predictions and share price targets for Crispr Therapeutics (CRSP)
Crispr Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-01 View latest technical analysis
10 day averaged volume of Crispr Therapeutics is 1178340
| Date | Daily Closing Price | Open | High | Low | Volume |
| 01 Fri Nov 2024 | 50.76 | 46.96 | 50.85 | 46.91 | 1.921 times |
| 31 Thu Oct 2024 | 46.39 | 47.76 | 47.99 | 46.30 | 1.086 times |
| 30 Wed Oct 2024 | 47.93 | 48.51 | 49.87 | 47.60 | 0.989 times |
| 29 Tue Oct 2024 | 48.94 | 49.53 | 49.75 | 48.44 | 1.006 times |
| 28 Mon Oct 2024 | 49.71 | 47.99 | 50.50 | 47.75 | 1.448 times |
| 25 Fri Oct 2024 | 47.36 | 47.96 | 48.88 | 47.26 | 0.941 times |
| 24 Thu Oct 2024 | 47.95 | 46.19 | 47.98 | 45.92 | 0.938 times |
| 23 Wed Oct 2024 | 46.00 | 47.95 | 47.96 | 45.44 | 1.551 times |
| 22 Tue Oct 2024 | 48.04 | 48.26 | 48.42 | 47.82 | 0.708 times |
| 21 Mon Oct 2024 | 48.51 | 48.59 | 48.94 | 48.20 | 0.669 times |
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 51, for a target of 49.1 or 47.6
Share price targets for Crispr Therapeutics (CRSP)
| Target Type | Value |
| Downside Target | 43.42 |
| Downside Target | 44.44 |
| Downside Target | 48.94 |
| Downside Target | 49.28 |
| Downside Target | 50.50 |
| Upside Target | 50.85 |
| Upside Target | 51.99 |
| Upside Target | 52.31 |
| Upside Target | 57.68 |
| Upside Target | 63.68 |
Intraday share price targets for Crispr Therapeutics (CRSP)
| Target Type | Value |
| Downside Intraday Target | 47.76 |
| Downside Intraday Target | 44.75 |
| Upside Intraday Target | 52.31 |
| Upside Intraday Target | 53.85 |
| Downside Intraday Target | 49.3 |
Weekly technical analysis of Crispr Therapeutics (CRSP)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 01 Fri Nov 2024 | 50.76 | 47.99 | 50.85 | 46.30 | 1.342 times |
| 25 Fri Oct 2024 | 47.36 | 48.59 | 48.94 | 45.44 | 1.167 times |
| 18 Fri Oct 2024 | 48.92 | 46.74 | 49.28 | 46.10 | 1.151 times |
| 11 Fri Oct 2024 | 46.85 | 45.43 | 47.50 | 44.44 | 0.773 times |
| 04 Fri Oct 2024 | 45.37 | 46.94 | 47.69 | 44.61 | 1.222 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Crispr Therapeutics (CRSP)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 01 Fri Nov 2024 | 50.76 | 46.96 | 50.85 | 46.91 | 0.092 times |
| 31 Thu Oct 2024 | 46.39 | 47.00 | 50.50 | 44.44 | 1.167 times |
| 30 Mon Sep 2024 | 46.98 | 47.37 | 51.99 | 43.42 | 0.769 times |
| 30 Fri Aug 2024 | 47.72 | 57.39 | 57.68 | 44.80 | 0.967 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Crispr Therapeutics (CRSP)
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Crispr Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Crispr Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Crispr Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 48.31 and Crispr Therapeutics (CRSP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Crispr Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Crispr Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Crispr Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 48.31 and Crispr Therapeutics (CRSP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.